Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin

J Biol Chem. 2000 Mar 24;275(12):8369-74. doi: 10.1074/jbc.275.12.8369.

Abstract

The tumor suppressor adenomatous polyposis coli (APC) is mutated in familial adenomatous polyposis and in sporadic colorectal tumors. APC forms a complex with beta-catenin, Axin, and glycogen synthase kinase-3beta and induces the degradation of beta-catenin. In the present study, we examined whether APC association with Axin is required for degradation of beta-catenin. We found that a fragment of APC that induces beta-catenin degradation was rendered inactive by disruption of its Axin-binding sites. Also, overexpression of an Axin fragment spanning the regulator of the G-protein signaling domain inhibited APC-mediated beta-catenin degradation. An APC fragment with mutated beta-catenin-binding sites but intact Axin-binding sites also failed to induce degradation of beta-catenin. These results suggest that APC requires interaction with Axin and beta-catenin to down-regulate beta-catenin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenomatous Polyposis Coli Protein
  • Amino Acid Sequence
  • Axin Protein
  • Binding Sites
  • Cytoskeletal Proteins / genetics*
  • Cytoskeletal Proteins / metabolism*
  • Down-Regulation
  • GTP-Binding Proteins
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Molecular Sequence Data
  • Neoplasm Proteins / metabolism*
  • Peptide Fragments / metabolism
  • Protein Binding
  • Proteins / metabolism*
  • Repressor Proteins*
  • Signal Transduction
  • Trans-Activators*
  • beta Catenin

Substances

  • Adenomatous Polyposis Coli Protein
  • Axin Protein
  • Cytoskeletal Proteins
  • Neoplasm Proteins
  • Peptide Fragments
  • Proteins
  • Repressor Proteins
  • Trans-Activators
  • beta Catenin
  • GTP-Binding Proteins